Bluepharma, leader of the CiNTech consortium - Technological Pole for Innovation, Translation and Industrialization of Complex Injectable Medicines - signed, on the 17th of September, the term of acceptance of the Mobilizing Agendas and Green Agendas for Business Innovation within the scope of the Recovery and Resilience.

CiNTech intends to promote the creation and training of the first Technological Pole entirely dedicated to complex injectable medicines in Portugal, in a global investment of 30 million euros corresponding to an incentive of around 21 million euros.

The consortium includes, in addition to Bluepharma, the University of Coimbra, the Iberian Institute of Nanotechnology (INL), and three SMEs (Biotrend, JPM and Joinsteel).